304 (PB084) - Pharmacological screening identified promising combination partners in marginal zone lymphoma models with secondary resistance to BTK and PI3K inhibitors
| Autor: | Arribas, A., Vultaggio, S., Andronache, A., Robusto, M., Fancelli, D., Cannas, E., Spriano, F., Tarantelli, C., Rossi, D., Zucca, E., Stathis, A., Varasi, M., Mercurio, C., Bertoni, F. |
|---|---|
| Zdroj: | In European Journal of Cancer October 2022 174 Supplement 1:S108-S108 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect